UBS AM’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Buy |
|
|||||
|
2025
Q1 | $3.53M | Buy |
|
|||||
|
2024
Q4 | $3.62M | Buy |
|
|||||
|
2024
Q3 | $2.5M | Sell |
|
|||||
|
2024
Q2 | $2.48M | Buy |
|
|||||
|
2024
Q1 | $1.75M | Hold |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $1.32M | Sell |
|
|||||
|
2023
Q2 | $2.01M | Hold |
|
|||||
|
2023
Q1 | $2.01M | Sell |
|
|||||
|
2022
Q4 | $2.04M | Sell |
|
|||||
|
2022
Q3 | $1.99M | Buy |
|
|||||
|
2022
Q2 | $1.52M | Sell |
|
|||||
|
2022
Q1 | $1.73M | Buy |
|
|||||
|
2021
Q4 | $1.28M | Sell |
|
|||||
|
2021
Q3 | $1.21M | Hold |
|
|||||
|
2021
Q2 | $1.39M | Buy |
|
|||||
|
2021
Q1 | $1.12M | Hold |
|
|||||
|
2020
Q4 | $1.07M | Hold |
|
|||||
|
2020
Q3 | $888K | Hold |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $557K | Sell |
|
|||||
|
2019
Q4 | $975K | Sell |
|
|||||
|
2019
Q3 | $1.31M | Buy |
|
|||||
|
2019
Q2 | $1.33M | Sell |
|
|||||
|
2019
Q1 | $5.96M | Buy |
|
|||||
|
2018
Q4 | $5.58M | Sell |
|
|||||
|
2018
Q3 | $8.92M | Buy |
|
|||||
|
2018
Q2 | $10.1M | Sell |
|
|||||
|
2018
Q1 | $8.32M | Sell |
|
|||||
|
2017
Q4 | $9.61M | Sell |
|
|||||
|
2017
Q3 | $9.86M | Buy |
|
|||||
|
2017
Q2 | $8.61M | Buy |
|
|||||
|
2017
Q1 | $555K | Buy |
|
|||||
|
2016
Q4 | $253K | Sell |
|
|||||
|
2016
Q3 | $430K | Sell |
|
|||||
|
2016
Q2 | $356K | Hold |
|
|||||
|
2016
Q1 | $267K | Sell |
|
|||||
|
2015
Q4 | $255K | Hold |
|
|||||
|
2015
Q3 | $267K | Hold |
|
|||||
|
2015
Q2 | $323K | Buy |
|